Anktiva BioShield Platform — Vax-Before-Travel

Anktiva BioShield Platform

Fact checked by Robert Carlson, MD

Jan 13

3 min read

Advance Immunotherapy 2.0 Presented at USA-Saudi Biotech Alliance Summit

ANKTIVA plus BCG vaccine is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS

Cancer vaccine

Fact checked by Robert Carlson, MD

Dec 20

4 min read

Europe recommends Access to Innovative Bladder Cancer Therapy

Bladder cancer therapy combined with BCG vaccine becomes available in Europe in 2026

BCG vaccine 2025

Fact checked by Robert Carlson, MD

Aug 13

3 min read

VA Hospitals to Administer ANKTIVA® to Bladder Cancer Patients

ANKTIVA plus BCG vaccine approved by US FDA

Michael E. DeBakey Department of Veterans Affairs Medical Center